Mr Prashant Patel

Prashant Patel qualified in medicine in 1993 in India and then trained to qualify as a General Surgeon with a special interest in pelvic surgery. He pursued a career in General Surgery in the UK until entering cancer research in 2002. He was awarded a PhD from the University of Birmingham whilst training as a Urologist. His research explored gene and immunotherapy for prostate cancer. He travelled to Perth (2010), Australia to complete a fellowship in urological cancer surgery where he had exposure to laparoscopic and robotic surgery. He has professional registration with the UK, India, USA and Australia as well as being awarded a Fellowship with the European Board of Urology.

In 2010 Prashant was appointed as a Senior Lecturer in Urology at the University of Birmingham and Consultant Urological Surgeon at the QE Hospital (UHB), to pursue a joint career in academic and clinical urology. He is an accredited by the GMC as a trainer and educational supervisor. He regularly lectures at the University of Birmingham and is a tutor for post-graduate programs. He has been on the committee of National Urology Trainee selection since 2011. He is on the teaching faculty at the British Association of Urological Surgeons for the FRCS (Urology) Examinations.

His international profile includes panellist and Chair on Bladder Cancer at the European Urology Annual Meetings over several years, Member of the Scientific Evaluation Committee for Translational Cancer Research at the French National Cancer Institute, and Frontiers Guest Associate Editor in Genitourinary Oncology.

His academic interests are to explore molecular markers in bladder cancer, immunotherapeutic approaches in all urological cancers and informatics. He is extensively published with >100 peer reviewed articles in journals and book chapters. He is the Chief Investigator on Gene therapy clinical trial and is also a Principal investigator in several prostate and bladder cancer studies. He is a grant holder of several trials and studies. His research interests are also outside the field of Urology involving large datasets (informatics) where his team explore disease and outcome trends. This area of research has also led to recommendations in national guidance. Prashant is also the theme lead in Clinical Research and Epidemiology for the Bladder Cancer Research Centre in the Institute of Cancer and Genomic Sciences.

Since 2019, Prashant has been the Head of Department (Clinical Service Lead) at University Hospitals Birmingham